Recherches "plusieurs pathologies"
SUMMIT- PUMA-NER-0502
An Open-label, Phase 2 Study of Neratinib in Patients With Solid Tumors With Somatic Human Epidermal Growth Factor Receptor (EGFR, HER2, HER3) Mutations or EGFR Gene Amplification.
Saint-Cloud
FRANCOIS-CLEMENT BIDARD